On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer (2024) Sinn BV, Sychra K, Untch M, Karn T, van Mackelenbergh M, Huober J, Schmitt W, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry (2023) Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, et al. Journal article PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, et al. Journal article Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci (2022) Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, Scott C, et al. Journal article Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial (2020) de Gregorio A, Häberle L, Fasching P, Müller V, Schrader I, Lorenz R, Forstbauer H, et al. Journal article Prediction and clinical utility of a contralateral breast cancer risk model (2019) Giardiello D, Steyerberg EW, Hauptmann M, Adank MA, Akdeniz D, Blomqvist C, Bojesen SE, et al. Journal article Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019) Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching P, Stone J, Southey MC, et al. Journal article Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto (2019) Laakmann E, Witzel I, Fasching P, Rezai M, Schem C, Solbach C, Tesch H, et al. Journal article Amide chemical exchange saturation transfer at 7T: A possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients (2018) Krikken E, Khlebnikov V, Zaiss M, Jibodh RA, Van Diest PJ, Luijten PR, Klomp DWJ, et al. Journal article, Original article